— Know what they know.
Not Investment Advice
Also trades as: 0M3Q.L (LSE) · $vol 1M · ZOE.DE (XETRA) · $vol 0M

ZTS NYSE

Zoetis Inc.
1W: -2.3% 1M: +9.5% 3M: +0.3% YTD: -37.6% 1Y: -46.2% 3Y: -52.0% 5Y: -60.2%
$78.23
-2.74 (-3.38%)
Pre-Market: $77.87 (-0.36, -0.46%)
Weekly Expected Move ±3.6%
$75 $78 $81 $84 $87
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 74 · $32.3B mcap · 412M float · 1.34% daily turnover · Short 41% of daily vol
Credit Risk of going bust: lower than 57% of companies Debt: 22.2% of company value Bonds: $301.2M held by 308 funds, 68 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.76 (down 98%), Zoetis Inc. would be worth roughly what it owes.
Total debt $9.24B against a stock market value of $32.33B.
Distance to default 5.81 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.52B (short-term plus half of long-term), stock volatility 40.4%; Altman Z 4.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$9.5B +2.3% ▲
5Y CAGR: +7.2%
Gross Profit
$6.7B +4.3% ▲
5Y CAGR: +8.4%
Operating Income
$3.6B +6.0% ▲
5Y CAGR: +9.7%
Net Income
$2.7B +7.5% ▲
5Y CAGR: +10.3%
EPS (Diluted)
$6.02 +10.1% ▲
5Y CAGR: +12.0%
EBITDA
$4.1B +5.1% ▲
5Y CAGR: +8.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$7.8B$8.1B$8.5B$9.3B$9.5B
YoY Growth+16.5%+3.9%+5.7%+8.3%+2.3%
Cost of Revenue$2.5B$2.6B$2.7B$2.9B$2.8B
Gross Profit$5.3B$5.5B$5.8B$6.4B$6.7B
Gross Margin68.3%67.8%68.3%69.1%70.5%
R&D Expenses$508M$539M$614M$686M$698M
SG&A Expenses$2.0B$2.0B$2.2B$2.3B$2.4B
Operating Expenses$2.5B$2.5B$2.8B$3.0B$3.1B
Operating Income$2.8B$2.9B$3.1B$3.4B$3.6B
Operating Margin36.0%36.2%35.9%36.6%38.0%
Interest Expense$236M$237M$258M$242M$243M
Income Before Tax$2.5B$2.7B$2.9B$3.1B$3.4B
Tax Expense$454M$545M$596M$637M$687M
Net Income$2.0B$2.1B$2.3B$2.5B$2.7B
Net Margin26.2%26.2%27.4%26.9%28.2%
EPS (Diluted)$4.27$4.49$5.07$5.47$6.02
EBITDA$3.2B$3.4B$3.7B$3.9B$4.1B
Shares Outstanding477M470M462M455M444M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms